Single treatment of BCH or anti-PD-L1 inhibited the growth of MB49-CR xenograft partially and combination treatment showed a synergistic effect (Fig. 7K, L), which further indicated SLC7A6 modulated immune response in cisplatin resistant BCa microenvironment. This evidence concerns the gene SLC7A6 and choreatic disease.